CS Diagnostics delays Form 10-K filing

CS Diagnostics Corp. notifies the SEC it cannot file its Annual Report on Form 10-K for the fiscal year ended December 31, 2025 within the prescribed time and is requesting the 15‑calendar‑day extension under Rule 12b-25.

Rhea-AI Filing Summary

CS Diagnostics Corp. notifies the SEC it cannot file its Annual Report on Form 10-K for the fiscal year ended December 31, 2025 within the prescribed time and is requesting the 15‑calendar‑day extension under Rule 12b-25. The company states it needs additional time to complete financial statements and for its independent auditor to finish audit procedures. The registrant currently expects to file within the permitted 15‑day extension period and anticipates its results for the fiscal year ended December 31, 2025 will show a 25% increase in revenue versus the prior year.

Insights

Corporate Reporting Analyst

Routine late‑filing notice tied to audit completion; projection disclosed.

The filing is a standard Rule 12b-25 notification that the company cannot timely file its Form 10-K and expects to use the 15‑calendar‑day extension to finalize audited financials. This is procedural rather than a corporate governance or liquidity event.

The registrant also discloses an operational metric: management anticipates a 25% increase in revenue for the fiscal year ended December 31, 2025. Stakeholders should look for the forthcoming Form 10-K for audited confirmation and detailed financials.

Key Figures

Form type: Form 10-K (late filing notice) Extension period expected: 15 calendar days Revenue change (anticipation): 25% increase +1 more

4 metrics

Form type Form 10-K (late filing notice) Annual report for fiscal year ended December 31, 2025

Extension period expected 15 calendar days Permitted under Rule 12b-25 for late filing

Revenue change (anticipation) 25% increase Anticipated for fiscal year ended December 31, 2025 versus prior year

Fiscal year end December 31, 2025 Reporting period referenced in the notification

Key Terms

Rule 12b-25, Form 10-K, independent registered public accounting firm

3 terms

Rule 12b-25 regulatory

"seeks relief pursuant to Rule 12b-25(b)"

Rule 12b-25 is an SEC filing provision that lets a company notify regulators and the public that it cannot file a required periodic report (like a quarterly or annual report) on time and explains the reason for the delay. For investors, the notice is a formal heads-up that financial information will arrive late—similar to a company calling to say it will be late turning in homework—so it signals increased uncertainty and may affect trading and risk assessments until the filing is available.

Form 10-K regulatory

"Annual Report on Form 10-K for the fiscal year ended December 31, 2025"

A Form 10-K is a comprehensive report that publicly traded companies are required to file annually with regulators. It provides a detailed overview of a company's financial health, operations, and risks, similar to a detailed health report. Investors use this information to assess the company's performance and make informed decisions about buying or selling its stock.

independent registered public accounting firm financial

"for its independent registered public accounting firm to complete its audit procedures"

An independent registered public accounting firm is an outside accounting company officially registered with the government regulator to examine and report on a public company's financial records and controls. Investors treat its reports like an impartial inspector’s certificate — they add credibility to financial statements, help spot errors or misleading claims, and reduce the risk that shareholders are relying on unchecked or biased numbers.

FAQ

Why did CS Diagnostics (CSDX) file a Form 12b-25?

They filed because they cannot complete the Form 10-K on time. The company needs extra time to finish its financial statements and for its independent auditor to complete audit procedures, and expects to use the 15‑calendar‑day extension permitted under Rule 12b-25.

When does CS Diagnostics expect to file the delayed Form 10-K?

They expect to file within the 15‑calendar‑day extension period. The notification states the registrant currently expects to complete required work and submit the Form 10-K during that permitted 15‑day window under Rule 12b-25.

What financial impact did CS Diagnostics disclose for FY 2025?

Management anticipates a 25% increase in revenue for FY 2025. This is a company projection included in the late‑filing notice; audited confirmation will appear in the forthcoming Form 10-K when filed.

Does the Form 12b-25 affect CS Diagnostics' reporting obligations?

The notice preserves a short extension but does not change obligations. Filing the Form 12b-25 requests relief to submit the Form 10-K within 15 days; the company remains subject to all SEC reporting rules and must file the audited report within that extension.

Who is the contact for CS Diagnostics regarding the late filing?

Contact listed: Mohammad EsSayed, phone +971 52-861-1930. The notification provides this contact for inquiries about the delayed Form 10-K and the company’s timetable to complete its audited financial statements.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/31/2026 - 06:02 AM Learn about SEC filing dates

UNITED STATES

SECURITES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 12b-25

NOTIFICATION OF LATE FILING

(Check one):	☒ Form 10-K	☐ Form 20-F	☐ Form 11-K
	☐ Form 10-Q	☐ Form 10-D	☐ Form N-CEN	☐ Form N-CSR

	For Period Ended:	December 31, 2025
	☐ Transition Report on Form 10-K
	☐ Transition Report on Form 20-F
	☐ Transition Report on Form 11-K
	☐ Transition Report on Form 10-Q
	For the Transition Period Ended:

PART I – REGISTRANT INFORMATION

CS Diagnostics Corp.

Full Name of Registrant

1603 Capitol Avenue, Suite 413,

Address of Principal Executive Office (Street and Number)

Cheyenne, WY 82001, USA

City, State and Zip Code

PART II – RULES 12b-25(b) AND (c)

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

☒ (a)   The reason described in reasonable detail in Part III of this Form could not be eliminated without unreasonable effort or expense;   (b)   The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-CEN or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and   (c)   The accountant’s statement or other exhibit required by rule 12b-25(c) has been attached if applicable.  

PART III – NARRATIVE

The registrant is unable to file its Annual Report on Form 10-K for the fiscal year ended December 31, 2025 within the prescribed time period without unreasonable effort or expense.

The registrant requires additional time to complete the preparation of its financial statements and for its independent registered public accounting firm to complete its audit procedures.

The registrant is working diligently to complete the required work and currently expects to file its Form 10-K within the fifteen (15) calendar day extension period permitted under Rule 12b-25.

PART IV – OTHER INFORMATION

(1) Name and telephone number of person to contact in regard to this notification

Mohammad EsSayed		+971		52-861-1930
(Name)		(Area Code)		(Telephone Number)

(2) Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s).                   ☒ Yes             ☐ No

(3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?                   ☒ Yes             ☐ No

If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

The registrant anticipates that its results of operations for the fiscal year ended December 31, 2025 will reflect an increase of 25% in revenue as compared to the corresponding period for the prior fiscal year.

CS Diagnostics, Corp.

(Name of Registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

Date      March 31, 2026 By /s/Mohammad Essayed